Arzeda

Seattle, WA · Founded 2008 · Privately Held (backing)

Developer of a synthetic biology technology designed to create new designer proteins and enzymes with less risk. Arzeda is based in Seattle, WA and was founded in 2008. It was valued at $150 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $109 million across 6 recorded rounds; the latest was a $4.5 million seed round in Aug 2025.

PMV mark · valuation
$149.5M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$109.2M
Last round
Seed Round
Aug 2025

Who backs Arzeda?

25 investors
InvestorType
US National Science FoundationOther
U.S. Department of EnergyOther
Sofinnova PartnersVenture capital
Arpa-E—
Casdin CapitalVenture capital
WRF CapitalOther
Fall Line CapitalVenture capital
OS FundVenture capital
Lewis & Clark PartnersGrowth equity
Bunge VenturesVenture capital
+ 15 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Arzeda investors

25 investors are on record for Arzeda, including US National Science Foundation, U.S. Department of Energy, Sofinnova Partners and Arpa-E. By type, the record holds 5 venture capital firms and 1 growth equity firm. The seed round in Aug 2025 drew 6 investors.

Free account
More of Arzeda with a free account
  • ·The complete investor list: 25 names
  • ·Watch Arzeda: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 25 firms already write checks for companies like Arzeda. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View